BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11536076)

  • 1. Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes.
    Zhou XP; Woodford-Richens K; Lehtonen R; Kurose K; Aldred M; Hampel H; Launonen V; Virta S; Pilarski R; Salovaara R; Bodmer WF; Conrad BA; Dunlop M; Hodgson SV; Iwama T; Järvinen H; Kellokumpu I; Kim JC; Leggett B; Markie D; Mecklin JP; Neale K; Phillips R; Piris J; Rozen P; Houlston RS; Aaltonen LA; Tomlinson IP; Eng C
    Am J Hum Genet; 2001 Oct; 69(4):704-11. PubMed ID: 11536076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large genomic deletions of SMAD4, BMPR1A and PTEN in juvenile polyposis.
    van Hattem WA; Brosens LA; de Leng WW; Morsink FH; Lens S; Carvalho R; Giardiello FM; Offerhaus GJ
    Gut; 2008 May; 57(5):623-7. PubMed ID: 18178612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile polyposis: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers.
    Friedl W; Uhlhaas S; Schulmann K; Stolte M; Loff S; Back W; Mangold E; Stern M; Knaebel HP; Sutter C; Weber RG; Pistorius S; Burger B; Propping P
    Hum Genet; 2002 Jul; 111(1):108-11. PubMed ID: 12136244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic conditions associated with intestinal juvenile polyps.
    Merg A; Howe JR
    Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):44-55. PubMed ID: 15264272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constipation, polyps, or cancer? Let PTEN predict your future.
    Eng C
    Am J Med Genet A; 2003 Nov; 122A(4):315-22. PubMed ID: 14518069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.
    Howe JR; Bair JL; Sayed MG; Anderson ME; Mitros FA; Petersen GM; Velculescu VE; Traverso G; Vogelstein B
    Nat Genet; 2001 Jun; 28(2):184-7. PubMed ID: 11381269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome.
    Carethers JM; Furnari FB; Zigman AF; Lavine JE; Jones MC; Graham GE; Teebi AS; Huang HJ; Ha HT; Chauhan DP; Chang CL; Cavenee WK; Boland CR
    Cancer Res; 1998 Jul; 58(13):2724-6. PubMed ID: 9661881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis.
    Woodford-Richens K; Bevan S; Churchman M; Dowling B; Jones D; Norbury CG; Hodgson SV; Desai D; Neale K; Phillips RK; Young J; Leggett B; Dunlop M; Rozen P; Eng C; Markie D; Rodriguez-Bigas MA; Sheridan E; Iwama T; Eccles D; Smith GT; Kim JC; Kim KM; Sampson JR; Evans G; Tejpar S; Bodmer WF; Tomlinson IP; Houlston RS
    Gut; 2000 May; 46(5):656-60. PubMed ID: 10764709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis.
    Sayed MG; Ahmed AF; Ringold JR; Anderson ME; Bair JL; Mitros FA; Lynch HT; Tinley ST; Petersen GM; Giardiello FM; Vogelstein B; Howe JR
    Ann Surg Oncol; 2002 Nov; 9(9):901-6. PubMed ID: 12417513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations.
    Howe JR; Sayed MG; Ahmed AF; Ringold J; Larsen-Haidle J; Merg A; Mitros FA; Vaccaro CA; Petersen GM; Giardiello FM; Tinley ST; Aaltonen LA; Lynch HT
    J Med Genet; 2004 Jul; 41(7):484-91. PubMed ID: 15235019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
    Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH
    Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in the PTEN gene in Israeli patients with Bannayan-Riley-Ruvalcaba syndrome and women with familial breast cancer.
    Figer A; Kaplan A; Frydman M; Lev D; Paswell J; Papa MZ; Goldman B; Friedman E
    Clin Genet; 2002 Oct; 62(4):298-302. PubMed ID: 12372056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome.
    Marsh DJ; Roth S; Lunetta KL; Hemminki A; Dahia PL; Sistonen P; Zheng Z; Caron S; van Orsouw NJ; Bodmer WF; Cottrell SE; Dunlop MG; Eccles D; Hodgson SV; Järvinen H; Kellokumpu I; Markie D; Neale K; Phillips R; Rozen P; Syngal S; Vijg J; Tomlinson IP; Aaltonen LA; Eng C
    Cancer Res; 1997 Nov; 57(22):5017-21. PubMed ID: 9371495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis syndromes: recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer.
    Boland CR; Idos GE; Durno C; Giardiello FM; Anderson JC; Burke CA; Dominitz JA; Gross S; Gupta S; Jacobson BC; Patel SG; Shaukat A; Syngal S; Robertson DJ
    Gastrointest Endosc; 2022 Jun; 95(6):1025-1047. PubMed ID: 35487765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-defined cancer risk in juvenile polyposis syndrome.
    Aytac E; Sulu B; Heald B; O'Malley M; LaGuardia L; Remzi FH; Kalady MF; Burke CA; Church JM
    Br J Surg; 2015 Jan; 102(1):114-8. PubMed ID: 25389115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.
    Houlston R; Bevan S; Williams A; Young J; Dunlop M; Rozen P; Eng C; Markie D; Woodford-Richens K; Rodriguez-Bigas MA; Leggett B; Neale K; Phillips R; Sheridan E; Hodgson S; Iwama T; Eccles D; Bodmer W; Tomlinson I
    Hum Mol Genet; 1998 Nov; 7(12):1907-12. PubMed ID: 9811934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis.
    Sweet K; Willis J; Zhou XP; Gallione C; Sawada T; Alhopuro P; Khoo SK; Patocs A; Martin C; Bridgeman S; Heinz J; Pilarski R; Lehtonen R; Prior TW; Frebourg T; Teh BT; Marchuk DA; Aaltonen LA; Eng C
    JAMA; 2005 Nov; 294(19):2465-73. PubMed ID: 16287957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel BMPR1A germline mutation in a Korean juvenile polyposis patient without SMAD4 mutation.
    Kim IJ; Park JH; Kang HC; Kim KH; Kim JH; Ku JL; Kang SB; Park SY; Lee JS; Park JG
    Clin Genet; 2003 Feb; 63(2):126-30. PubMed ID: 12630959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap of Juvenile polyposis syndrome and Cowden syndrome due to de novo chromosome 10 deletion involving BMPR1A and PTEN: implications for treatment and surveillance.
    Alimi A; Weeth-Feinstein LA; Stettner A; Caldera F; Weiss JM
    Am J Med Genet A; 2015 Jun; 167(6):1305-8. PubMed ID: 25846706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.